Search research articles
Contact Us
Filters
Showing results (21-30 of 35) with videos related to
Page
of 4
Sort By:
Acta Neuropathologica
|
April 30, 2014
Human pontine glioma cells can induce murine tumors
Viola Caretti, A Charlotte P Sewing, Tonny Lagerweij, et al.
Angiogenesis
|
July 13, 2017
Optical clearing and fluorescence deep-tissue imaging for 3D quantitative analysis of the brain tumor microenvironment
Tonny Lagerweij, Sophie A Dusoswa, Adrian Negrean, et al.
Molecular Cancer Therapeutics
|
September 30, 2017
Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma
Ravi S Narayan, Ana Gasol, Paul L G Slangen, et al.
Neuro-Oncology
|
September 11, 2019
MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumors
Michaël H Meel, Miriam Guillén Navarro, Mark C de Gooijer, et al.
Ebiomedicine
|
December 25, 2018
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
Rocco Sciarrillo, Anna Wojtuszkiewicz, Btissame El Hassouni, et al.
Molecular Cancer Therapeutics
|
June 22, 2016
Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models
Marc H A Jansen, Tonny Lagerweij, A Charlotte P Sewing, et al.
The Journal of Biological Chemistry
|
September 15, 2019
The human cytomegalovirus-encoded G protein-coupled receptor UL33 exhibits oncomodulatory properties
Jeffrey R van Senten, Maarten P Bebelman, Tian Shu Fan, et al.
Oncogene
|
May 1, 2018
The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth
Raimond Heukers, Tian Shu Fan, Raymond H de Wit, et al.
British Journal of Cancer
|
June 5, 2020
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds
Giovanna Li Petri, Btissame El Hassouni, Rocco Sciarrillo, et al.
Journal of the National Cancer Institute
|
August 14, 2013
Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs
Bakhos A Tannous, Mariam Kerami, Petra M Van der Stoop, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 35) with videos related to
Sort By:
Page
of 4
Acta Neuropathologica
|
April 30, 2014
Human pontine glioma cells can induce murine tumors
Viola Caretti, A Charlotte P Sewing, Tonny Lagerweij, et al.
Angiogenesis
|
July 13, 2017
Optical clearing and fluorescence deep-tissue imaging for 3D quantitative analysis of the brain tumor microenvironment
Tonny Lagerweij, Sophie A Dusoswa, Adrian Negrean, et al.
Molecular Cancer Therapeutics
|
September 30, 2017
Identification of MEK162 as a Radiosensitizer for the Treatment of Glioblastoma
Ravi S Narayan, Ana Gasol, Paul L G Slangen, et al.
Neuro-Oncology
|
September 11, 2019
MEK/MELK inhibition and blood-brain barrier deficiencies in atypical teratoid/rhabdoid tumors
Michaël H Meel, Miriam Guillén Navarro, Mark C de Gooijer, et al.
Ebiomedicine
|
December 25, 2018
Splicing modulation as novel therapeutic strategy against diffuse malignant peritoneal mesothelioma
Rocco Sciarrillo, Anna Wojtuszkiewicz, Btissame El Hassouni, et al.
Molecular Cancer Therapeutics
|
June 22, 2016
Bevacizumab Targeting Diffuse Intrinsic Pontine Glioma: Results of 89Zr-Bevacizumab PET Imaging in Brain Tumor Models
Marc H A Jansen, Tonny Lagerweij, A Charlotte P Sewing, et al.
The Journal of Biological Chemistry
|
September 15, 2019
The human cytomegalovirus-encoded G protein-coupled receptor UL33 exhibits oncomodulatory properties
Jeffrey R van Senten, Maarten P Bebelman, Tian Shu Fan, et al.
Oncogene
|
May 1, 2018
The constitutive activity of the virally encoded chemokine receptor US28 accelerates glioblastoma growth
Raimond Heukers, Tian Shu Fan, Raymond H de Wit, et al.
British Journal of Cancer
|
June 5, 2020
Impact of hypoxia on chemoresistance of mesothelioma mediated by the proton-coupled folate transporter, and preclinical activity of new anti-LDH-A compounds
Giovanna Li Petri, Btissame El Hassouni, Rocco Sciarrillo, et al.
Journal of the National Cancer Institute
|
August 14, 2013
Effects of the selective MPS1 inhibitor MPS1-IN-3 on glioblastoma sensitivity to antimitotic drugs
Bakhos A Tannous, Mariam Kerami, Petra M Van der Stoop, et al.
Page
of 4